Let's look at the global statistics
Global infections: 64,527,868
Change over yesterday: 633,684
Nations with most cases: US (13,924,956), India (9,534,964), Brazil (6,436,650), Russia (2,327,105), France(2,275,677).
Special: How and why UK approved vaccine ahead of US, EU
The United Kingdom became the first country in the world to approve Pfizer vaccine ahead of European Union and United States, paving way for mass immunisation of vulnerable groups.
How did Britain get ahead of EU: The UK still remains under the authority of the EU medical regulator until the end of the Brexit transition. But, Britain used an exception in case of a pandemic for temporary authorisation of the vaccine prior to EU. Scientists and clinicians at the UK regulatory agency had “worked round the clock” to review more than 1,000 pages of information as and when data arrived from the Pfizer trial. The EU regulator has delayed formal assessments of vaccines, citing the need for 'extensive' data for conditional marketing authorisation. The first vaccinations in Europe are unlikely to start unil next year.
Read more to know about the regulatory differences between UK and EU.
Why US is taking longer than UK for approval: UK and US analyse vaccine data differently. The US drug regulator is known for its rigor of vaccine reviews, even if it involves reanalysing raw data from the trials to validate the results and turning over thousands of documents. On the contrary, UK regulators depend heavily on companies’ own analyses. Unless there are large anomalies in the data, the decisions will be based on company provided-reports. However, scientists and industry experts believe British regulators maintain high standards and often set the bar for other country approvals. Both the countries' regulators consult outside experts to make a decision, but in case of Britian, the panel has the flexibility to review data and meet as it needs to, allowing it to move more quickly.
Read here